RGC
ACLS icon

Roberts, Glore & Co’s Axcelis ACLS Stock Holding History

Roberts, Glore & Co’s Portfolio ACLS Stock Details ACLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Buy
+1,149
New +$170K 0.05% 231

Other funds holding ACLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Roberts, Glore & Co's ACLS Position: Q2 2026 in Review

Roberts, Glore & Co opened a new position in Axcelis (ACLS) in Q2 2026: 1,149 shares worth $218K. The stake represents 0.05% of the portfolio and ranks #231 among its holdings.

439 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Roberts, Glore & Co held 1,149 shares of Axcelis worth $218K as of Q2 2026.
  • Axcelis was a new Roberts, Glore & Co position in Q2 2026.
  • Axcelis made up 0.05% of Roberts, Glore & Co's portfolio in Q2 2026, its #231 holding.
  • 439 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Roberts, Glore & Co's 13F filing for Q2 2026, filed 11 Aug 2026.